Journal of Clinical Oncology

Reply to H. Zetterberg et al.

Journal of Clinical Oncology

James L. Rubenstein, Lingjing Chen, Cigall Kadoch, Sushmita Roy, Chris Becker, Howard Schulman

In Reply.

Journal of Clinical Oncology

James Rubenstein, Lauren Abrey, Ranjana Advani, Marc Shuman, Tony Tsai, Joan O'Brien

Treatment of primary CNS lymphoma with induction high-dose methotrexate, temozolomide, rituximab followed by consolidation cytarabine/etoposide: A pilot study with biomarker analysis.

Journal of Clinical Oncology

S. Issa, J. Hwang, J. Karch, J. Fridlyand, M. Prados, T. Batchelor, K. Aldape, C. Haqq, L. Damon, J. Rubenstein

Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis.

Journal of Clinical Oncology

J. L. Rubenstein, A. Shen, L. Abrey, D. Combs, C. Haqq, L. Damon, J. O'Brien, P. O'Connor, M. Prados, M. Shuman

Results from a phase I study of intraventricular administration of rituximab in patients with recurrent lymphomatous meningitis.

Journal of Clinical Oncology

J. L. Rubenstein, A. Shen, L. Abrey, D. Combs, C. Haqq, L. Damon, J. O'Brien, P. O'Connor, M. Prados, M. Shuman

Pages